180 related articles for article (PubMed ID: 32441827)
1. Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients - a retrospective study.
Osorio-Jaramillo E; Haasnoot GW; Kaider A; Schaefer AK; Haberl T; Goekler J; Angleitner P; Moayedifar R; Zuckermann A; Fischer GF; Laufer G; Claas FHJ; Aliabadi-Zuckermann AZ
Transpl Int; 2020 Sep; 33(9):1078-1088. PubMed ID: 32441827
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
[TBL] [Abstract][Full Text] [Related]
4. Eplet matching in pediatric heart transplantation: The SickKids experience.
Cardoso B; Wang J; Kiernan J; Dipchand AI
J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
[TBL] [Abstract][Full Text] [Related]
5. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
[TBL] [Abstract][Full Text] [Related]
6. Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.
Alves TA; Nascimento E; de Castro LB; Fabreti-Oliveira RA
Transpl Immunol; 2023 Oct; 80():101908. PubMed ID: 37536379
[TBL] [Abstract][Full Text] [Related]
7. Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
Firoz A; Geier S; Yanagida R; Hamad E; Rakita V; Zhao H; Kashem M; Toyoda Y
J Card Fail; 2024 Feb; 30(2):362-372. PubMed ID: 37422273
[TBL] [Abstract][Full Text] [Related]
8. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance.
Nilsson J; Ansari D; Ohlsson M; Höglund P; Liedberg AS; Smith JG; Nugues P; Andersson B
J Am Heart Assoc; 2019 Aug; 8(15):e011124. PubMed ID: 31339067
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
13. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
[TBL] [Abstract][Full Text] [Related]
14. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
[TBL] [Abstract][Full Text] [Related]
15. What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients.
Shi X; Lv J; Han W; Zhong X; Xie X; Su B; Ding J
BMC Nephrol; 2018 May; 19(1):116. PubMed ID: 29776389
[TBL] [Abstract][Full Text] [Related]
16. The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors.
Sutherland DE; Morrow CE; Kaufman D; Fryd DS; Najarian JS; Burke M; Noreen H; Segall M; Bach FH
Transplantation; 1983 Dec; 36(6):643-7. PubMed ID: 6362140
[TBL] [Abstract][Full Text] [Related]
17. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
Bunnapradist S; Hong A; Lee B; Takemoto SK
Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
[TBL] [Abstract][Full Text] [Related]
19. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
[TBL] [Abstract][Full Text] [Related]
20. Effect of amino acid mismatch in the UNOS dataset.
Sasaki N; El-Awar N; Idica A
Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
